However, type 2 diabetes is expected to develop in 20–50% of these women within 10–20 years [6,7], and the GDM offspring shows a two- to eightfold increased risk of obesity, metabolic syndrome, type 2 diabetes, and impaired insulin secretion and sensitivity than offspring of women without GDM [8,9]. This evidence concerns the gene INS and gestational diabetes.